nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—lung cancer	0.264	1	CbGaD
Tolvaptan—ABCB1—Topotecan—lung cancer	0.0389	0.0864	CbGbCtD
Tolvaptan—ABCB1—Gefitinib—lung cancer	0.0355	0.079	CbGbCtD
Tolvaptan—ABCB1—Vinorelbine—lung cancer	0.0274	0.0609	CbGbCtD
Tolvaptan—CYP3A4—Topotecan—lung cancer	0.0233	0.0518	CbGbCtD
Tolvaptan—ABCB1—Crizotinib—lung cancer	0.0218	0.0484	CbGbCtD
Tolvaptan—CYP3A4—Gefitinib—lung cancer	0.0213	0.0473	CbGbCtD
Tolvaptan—ABCB1—Gemcitabine—lung cancer	0.0213	0.0473	CbGbCtD
Tolvaptan—ABCB1—Erlotinib—lung cancer	0.021	0.0467	CbGbCtD
Tolvaptan—CYP3A4—Teniposide—lung cancer	0.0206	0.0459	CbGbCtD
Tolvaptan—ABCB1—Paclitaxel—lung cancer	0.0192	0.0428	CbGbCtD
Tolvaptan—ABCB1—Irinotecan—lung cancer	0.019	0.0422	CbGbCtD
Tolvaptan—ABCB1—Vinblastine—lung cancer	0.0169	0.0375	CbGbCtD
Tolvaptan—CYP3A4—Vinorelbine—lung cancer	0.0164	0.0365	CbGbCtD
Tolvaptan—ABCB1—Cisplatin—lung cancer	0.0155	0.0344	CbGbCtD
Tolvaptan—ABCB1—Etoposide—lung cancer	0.0152	0.0338	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—lung cancer	0.0139	0.0309	CbGbCtD
Tolvaptan—CYP3A4—Crizotinib—lung cancer	0.0131	0.029	CbGbCtD
Tolvaptan—CYP3A4—Erlotinib—lung cancer	0.0126	0.028	CbGbCtD
Tolvaptan—CYP3A4—Paclitaxel—lung cancer	0.0115	0.0256	CbGbCtD
Tolvaptan—CYP3A4—Irinotecan—lung cancer	0.0114	0.0253	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—lung cancer	0.0104	0.023	CbGbCtD
Tolvaptan—CYP3A4—Vinblastine—lung cancer	0.0101	0.0225	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—lung cancer	0.01	0.0223	CbGbCtD
Tolvaptan—CYP3A4—Etoposide—lung cancer	0.00911	0.0202	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—lung cancer	0.00833	0.0185	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—lung cancer	0.00621	0.0138	CbGbCtD
Tolvaptan—AVPR1A—respiratory system—lung cancer	0.00217	0.316	CbGeAlD
Tolvaptan—AVPR2—respiratory system—lung cancer	0.0018	0.262	CbGeAlD
Tolvaptan—Zafirlukast—ABCG2—lung cancer	0.0012	0.297	CrCbGaD
Tolvaptan—AVPR1A—lung—lung cancer	0.00115	0.168	CbGeAlD
Tolvaptan—Vismodegib—ABCG2—lung cancer	0.00102	0.252	CrCbGaD
Tolvaptan—AVPR2—lung—lung cancer	0.000955	0.139	CbGeAlD
Tolvaptan—Zafirlukast—CYP2E1—lung cancer	0.000953	0.236	CrCbGaD
Tolvaptan—Vismodegib—ALB—lung cancer	0.000443	0.11	CrCbGaD
Tolvaptan—Vismodegib—ABCB1—lung cancer	0.000423	0.105	CrCbGaD
Tolvaptan—Malnutrition—Cisplatin—lung cancer	0.00023	0.00132	CcSEcCtD
Tolvaptan—Body temperature increased—Erlotinib—lung cancer	0.000229	0.00131	CcSEcCtD
Tolvaptan—Ill-defined disorder—Gemcitabine—lung cancer	0.000229	0.00131	CcSEcCtD
Tolvaptan—Malaise—Irinotecan—lung cancer	0.000229	0.00131	CcSEcCtD
Tolvaptan—Syncope—Irinotecan—lung cancer	0.000227	0.0013	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—lung cancer	0.000226	0.00129	CcSEcCtD
Tolvaptan—Cardiac disorder—Etoposide—lung cancer	0.000225	0.00129	CcSEcCtD
Tolvaptan—Loss of consciousness—Irinotecan—lung cancer	0.000223	0.00127	CcSEcCtD
Tolvaptan—Malaise—Gemcitabine—lung cancer	0.000223	0.00127	CcSEcCtD
Tolvaptan—Hypersensitivity—Vinblastine—lung cancer	0.000222	0.00127	CcSEcCtD
Tolvaptan—Renal failure—Docetaxel—lung cancer	0.00022	0.00126	CcSEcCtD
Tolvaptan—Cardiac disorder—Paclitaxel—lung cancer	0.00022	0.00126	CcSEcCtD
Tolvaptan—Angiopathy—Etoposide—lung cancer	0.00022	0.00126	CcSEcCtD
Tolvaptan—Immune system disorder—Etoposide—lung cancer	0.000219	0.00125	CcSEcCtD
Tolvaptan—Mediastinal disorder—Etoposide—lung cancer	0.000218	0.00125	CcSEcCtD
Tolvaptan—Decreased appetite—Vinorelbine—lung cancer	0.000218	0.00125	CcSEcCtD
Tolvaptan—Asthenia—Vinblastine—lung cancer	0.000217	0.00124	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000217	0.00124	CcSEcCtD
Tolvaptan—Hypersensitivity—Topotecan—lung cancer	0.000216	0.00124	CcSEcCtD
Tolvaptan—Angiopathy—Paclitaxel—lung cancer	0.000216	0.00123	CcSEcCtD
Tolvaptan—Constipation—Vinorelbine—lung cancer	0.000215	0.00123	CcSEcCtD
Tolvaptan—Immune system disorder—Paclitaxel—lung cancer	0.000215	0.00123	CcSEcCtD
Tolvaptan—Mediastinal disorder—Paclitaxel—lung cancer	0.000214	0.00122	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—lung cancer	0.000214	0.00122	CcSEcCtD
Tolvaptan—Ill-defined disorder—Cisplatin—lung cancer	0.000214	0.00122	CcSEcCtD
Tolvaptan—Discomfort—Irinotecan—lung cancer	0.000213	0.00122	CcSEcCtD
Tolvaptan—Asthenia—Topotecan—lung cancer	0.00021	0.0012	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000209	0.00119	CcSEcCtD
Tolvaptan—Asthenia—Erlotinib—lung cancer	0.000208	0.00119	CcSEcCtD
Tolvaptan—Discomfort—Gemcitabine—lung cancer	0.000208	0.00119	CcSEcCtD
Tolvaptan—Malaise—Cisplatin—lung cancer	0.000208	0.00119	CcSEcCtD
Tolvaptan—Pruritus—Topotecan—lung cancer	0.000208	0.00119	CcSEcCtD
Tolvaptan—Anaphylactic shock—Irinotecan—lung cancer	0.000207	0.00118	CcSEcCtD
Tolvaptan—Malnutrition—Paclitaxel—lung cancer	0.000207	0.00118	CcSEcCtD
Tolvaptan—Feeling abnormal—Vinorelbine—lung cancer	0.000207	0.00118	CcSEcCtD
Tolvaptan—Diarrhoea—Vinblastine—lung cancer	0.000207	0.00118	CcSEcCtD
Tolvaptan—Dysgeusia—Etoposide—lung cancer	0.000207	0.00118	CcSEcCtD
Tolvaptan—Pruritus—Erlotinib—lung cancer	0.000205	0.00117	CcSEcCtD
Tolvaptan—Shock—Irinotecan—lung cancer	0.000204	0.00116	CcSEcCtD
Tolvaptan—Nervous system disorder—Irinotecan—lung cancer	0.000203	0.00116	CcSEcCtD
Tolvaptan—Dysgeusia—Paclitaxel—lung cancer	0.000202	0.00116	CcSEcCtD
Tolvaptan—Anaphylactic shock—Gemcitabine—lung cancer	0.000202	0.00115	CcSEcCtD
Tolvaptan—Diarrhoea—Topotecan—lung cancer	0.000201	0.00115	CcSEcCtD
Tolvaptan—Dizziness—Vinblastine—lung cancer	0.0002	0.00114	CcSEcCtD
Tolvaptan—Urinary tract disorder—Docetaxel—lung cancer	0.000199	0.00114	CcSEcCtD
Tolvaptan—Diarrhoea—Erlotinib—lung cancer	0.000199	0.00113	CcSEcCtD
Tolvaptan—Body temperature increased—Vinorelbine—lung cancer	0.000198	0.00113	CcSEcCtD
Tolvaptan—Connective tissue disorder—Docetaxel—lung cancer	0.000198	0.00113	CcSEcCtD
Tolvaptan—Nervous system disorder—Gemcitabine—lung cancer	0.000198	0.00113	CcSEcCtD
Tolvaptan—Urethral disorder—Docetaxel—lung cancer	0.000197	0.00113	CcSEcCtD
Tolvaptan—Anorexia—Irinotecan—lung cancer	0.000197	0.00113	CcSEcCtD
Tolvaptan—Skin disorder—Gemcitabine—lung cancer	0.000196	0.00112	CcSEcCtD
Tolvaptan—Ill-defined disorder—Etoposide—lung cancer	0.000196	0.00112	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000195	0.00111	CcSEcCtD
Tolvaptan—Dizziness—Topotecan—lung cancer	0.000194	0.00111	CcSEcCtD
Tolvaptan—ABCB1—respiratory system—lung cancer	0.000194	0.0282	CbGeAlD
Tolvaptan—Discomfort—Cisplatin—lung cancer	0.000194	0.00111	CcSEcCtD
Tolvaptan—Anorexia—Gemcitabine—lung cancer	0.000192	0.0011	CcSEcCtD
Tolvaptan—Dizziness—Erlotinib—lung cancer	0.000192	0.0011	CcSEcCtD
Tolvaptan—Ill-defined disorder—Paclitaxel—lung cancer	0.000192	0.0011	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—lung cancer	0.000191	0.00109	CcSEcCtD
Tolvaptan—Malaise—Etoposide—lung cancer	0.00019	0.00109	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—lung cancer	0.00019	0.00108	CcSEcCtD
Tolvaptan—Headache—Vinblastine—lung cancer	0.000189	0.00108	CcSEcCtD
Tolvaptan—Anaphylactic shock—Cisplatin—lung cancer	0.000188	0.00107	CcSEcCtD
Tolvaptan—Cardiac disorder—Docetaxel—lung cancer	0.000187	0.00107	CcSEcCtD
Tolvaptan—Malaise—Paclitaxel—lung cancer	0.000186	0.00107	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—lung cancer	0.000186	0.00106	CcSEcCtD
Tolvaptan—Syncope—Paclitaxel—lung cancer	0.000185	0.00106	CcSEcCtD
Tolvaptan—Loss of consciousness—Etoposide—lung cancer	0.000185	0.00106	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—lung cancer	0.000185	0.00106	CcSEcCtD
Tolvaptan—Hypersensitivity—Vinorelbine—lung cancer	0.000185	0.00106	CcSEcCtD
Tolvaptan—Nervous system disorder—Cisplatin—lung cancer	0.000184	0.00105	CcSEcCtD
Tolvaptan—Headache—Topotecan—lung cancer	0.000184	0.00105	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—lung cancer	0.000183	0.00104	CcSEcCtD
Tolvaptan—Skin disorder—Cisplatin—lung cancer	0.000182	0.00104	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—lung cancer	0.000182	0.00104	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—lung cancer	0.000182	0.00104	CcSEcCtD
Tolvaptan—Headache—Erlotinib—lung cancer	0.000182	0.00104	CcSEcCtD
Tolvaptan—Loss of consciousness—Paclitaxel—lung cancer	0.000182	0.00104	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000182	0.00104	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—lung cancer	0.000181	0.00104	CcSEcCtD
Tolvaptan—Asthenia—Vinorelbine—lung cancer	0.00018	0.00103	CcSEcCtD
Tolvaptan—Decreased appetite—Irinotecan—lung cancer	0.00018	0.00103	CcSEcCtD
Tolvaptan—Nausea—Vinblastine—lung cancer	0.000179	0.00103	CcSEcCtD
Tolvaptan—Anorexia—Cisplatin—lung cancer	0.000179	0.00102	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Irinotecan—lung cancer	0.000179	0.00102	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000178	0.00102	CcSEcCtD
Tolvaptan—Pruritus—Vinorelbine—lung cancer	0.000178	0.00101	CcSEcCtD
Tolvaptan—Discomfort—Etoposide—lung cancer	0.000177	0.00101	CcSEcCtD
Tolvaptan—Constipation—Irinotecan—lung cancer	0.000177	0.00101	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—lung cancer	0.000175	0.001	CcSEcCtD
Tolvaptan—Decreased appetite—Gemcitabine—lung cancer	0.000175	0.001	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000175	0.000999	CcSEcCtD
Tolvaptan—Nausea—Topotecan—lung cancer	0.000174	0.000996	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000174	0.000995	CcSEcCtD
Tolvaptan—Discomfort—Paclitaxel—lung cancer	0.000174	0.000994	CcSEcCtD
Tolvaptan—Constipation—Gemcitabine—lung cancer	0.000172	0.000985	CcSEcCtD
Tolvaptan—Nausea—Erlotinib—lung cancer	0.000172	0.000985	CcSEcCtD
Tolvaptan—Dry mouth—Paclitaxel—lung cancer	0.000172	0.000984	CcSEcCtD
Tolvaptan—Anaphylactic shock—Etoposide—lung cancer	0.000172	0.000984	CcSEcCtD
Tolvaptan—Diarrhoea—Vinorelbine—lung cancer	0.000172	0.000981	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—lung cancer	0.000172	0.000981	CcSEcCtD
Tolvaptan—Feeling abnormal—Irinotecan—lung cancer	0.000171	0.000975	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—lung cancer	0.00017	0.000973	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—lung cancer	0.000169	0.000966	CcSEcCtD
Tolvaptan—Anaphylactic shock—Paclitaxel—lung cancer	0.000169	0.000965	CcSEcCtD
Tolvaptan—Skin disorder—Etoposide—lung cancer	0.000167	0.000956	CcSEcCtD
Tolvaptan—Feeling abnormal—Gemcitabine—lung cancer	0.000166	0.000949	CcSEcCtD
Tolvaptan—Shock—Paclitaxel—lung cancer	0.000166	0.000949	CcSEcCtD
Tolvaptan—Dizziness—Vinorelbine—lung cancer	0.000166	0.000948	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—lung cancer	0.000166	0.000948	CcSEcCtD
Tolvaptan—Nervous system disorder—Paclitaxel—lung cancer	0.000166	0.000946	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—lung cancer	0.000164	0.000938	CcSEcCtD
Tolvaptan—Anorexia—Etoposide—lung cancer	0.000164	0.000938	CcSEcCtD
Tolvaptan—Skin disorder—Paclitaxel—lung cancer	0.000164	0.000937	CcSEcCtD
Tolvaptan—Body temperature increased—Irinotecan—lung cancer	0.000164	0.000935	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000164	0.000935	CcSEcCtD
Tolvaptan—Decreased appetite—Cisplatin—lung cancer	0.000163	0.000934	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Cisplatin—lung cancer	0.000162	0.000927	CcSEcCtD
Tolvaptan—ABCB1—epithelium—lung cancer	0.000162	0.0236	CbGeAlD
Tolvaptan—Anorexia—Paclitaxel—lung cancer	0.000161	0.00092	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.00016	0.000916	CcSEcCtD
Tolvaptan—Body temperature increased—Gemcitabine—lung cancer	0.000159	0.000911	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—lung cancer	0.000159	0.000908	CcSEcCtD
Tolvaptan—Headache—Vinorelbine—lung cancer	0.000157	0.000898	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—lung cancer	0.000157	0.000898	CcSEcCtD
Tolvaptan—Feeling abnormal—Cisplatin—lung cancer	0.000155	0.000885	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—lung cancer	0.000154	0.000881	CcSEcCtD
Tolvaptan—Hypersensitivity—Irinotecan—lung cancer	0.000152	0.000871	CcSEcCtD
Tolvaptan—Decreased appetite—Etoposide—lung cancer	0.00015	0.000855	CcSEcCtD
Tolvaptan—Nausea—Vinorelbine—lung cancer	0.000149	0.000852	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Etoposide—lung cancer	0.000149	0.000849	CcSEcCtD
Tolvaptan—Body temperature increased—Cisplatin—lung cancer	0.000149	0.000849	CcSEcCtD
Tolvaptan—Asthenia—Irinotecan—lung cancer	0.000148	0.000849	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000148	0.000847	CcSEcCtD
Tolvaptan—Constipation—Etoposide—lung cancer	0.000147	0.000841	CcSEcCtD
Tolvaptan—Decreased appetite—Paclitaxel—lung cancer	0.000147	0.000839	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—lung cancer	0.000146	0.000834	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000146	0.000833	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—lung cancer	0.000145	0.000829	CcSEcCtD
Tolvaptan—Asthenia—Gemcitabine—lung cancer	0.000145	0.000827	CcSEcCtD
Tolvaptan—Constipation—Paclitaxel—lung cancer	0.000144	0.000825	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—lung cancer	0.000143	0.000819	CcSEcCtD
Tolvaptan—ABCB1—trachea—lung cancer	0.000143	0.0209	CbGeAlD
Tolvaptan—Anaphylactic shock—Docetaxel—lung cancer	0.000143	0.000818	CcSEcCtD
Tolvaptan—Pruritus—Gemcitabine—lung cancer	0.000143	0.000815	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—lung cancer	0.000142	0.000813	CcSEcCtD
Tolvaptan—Feeling abnormal—Etoposide—lung cancer	0.000142	0.000811	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—lung cancer	0.000142	0.000809	CcSEcCtD
Tolvaptan—Diarrhoea—Irinotecan—lung cancer	0.000142	0.000809	CcSEcCtD
Tolvaptan—Shock—Docetaxel—lung cancer	0.000141	0.000804	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—lung cancer	0.00014	0.000802	CcSEcCtD
Tolvaptan—Feeling abnormal—Paclitaxel—lung cancer	0.000139	0.000795	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—lung cancer	0.000139	0.000794	CcSEcCtD
Tolvaptan—Hypersensitivity—Cisplatin—lung cancer	0.000138	0.000791	CcSEcCtD
Tolvaptan—Diarrhoea—Gemcitabine—lung cancer	0.000138	0.000788	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—lung cancer	0.000138	0.000786	CcSEcCtD
Tolvaptan—Dizziness—Irinotecan—lung cancer	0.000137	0.000782	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—lung cancer	0.000136	0.000779	CcSEcCtD
Tolvaptan—Body temperature increased—Etoposide—lung cancer	0.000136	0.000778	CcSEcCtD
Tolvaptan—Asthenia—Cisplatin—lung cancer	0.000135	0.000771	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—lung cancer	0.000135	0.00077	CcSEcCtD
Tolvaptan—Body temperature increased—Paclitaxel—lung cancer	0.000133	0.000763	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—lung cancer	0.000132	0.000753	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—lung cancer	0.000131	0.000749	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—lung cancer	0.000131	0.000748	CcSEcCtD
Tolvaptan—Headache—Irinotecan—lung cancer	0.00013	0.000741	CcSEcCtD
Tolvaptan—Diarrhoea—Cisplatin—lung cancer	0.000129	0.000735	CcSEcCtD
Tolvaptan—Hypersensitivity—Etoposide—lung cancer	0.000127	0.000725	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—lung cancer	0.000126	0.000722	CcSEcCtD
Tolvaptan—Headache—Gemcitabine—lung cancer	0.000126	0.000722	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—lung cancer	0.000124	0.000711	CcSEcCtD
Tolvaptan—Hypersensitivity—Paclitaxel—lung cancer	0.000124	0.000711	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—lung cancer	0.000124	0.000709	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—lung cancer	0.000124	0.000707	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—lung cancer	0.000123	0.000706	CcSEcCtD
Tolvaptan—Asthenia—Etoposide—lung cancer	0.000123	0.000706	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—lung cancer	0.000123	0.000706	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—lung cancer	0.000123	0.000704	CcSEcCtD
Tolvaptan—Nausea—Irinotecan—lung cancer	0.000123	0.000703	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—lung cancer	0.000122	0.000699	CcSEcCtD
Tolvaptan—Pruritus—Etoposide—lung cancer	0.000122	0.000696	CcSEcCtD
Tolvaptan—Asthenia—Paclitaxel—lung cancer	0.000121	0.000692	CcSEcCtD
Tolvaptan—Nausea—Gemcitabine—lung cancer	0.00012	0.000684	CcSEcCtD
Tolvaptan—Pruritus—Paclitaxel—lung cancer	0.000119	0.000682	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—lung cancer	0.000118	0.000674	CcSEcCtD
Tolvaptan—Diarrhoea—Etoposide—lung cancer	0.000118	0.000673	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—lung cancer	0.000117	0.00067	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—lung cancer	0.000117	0.000667	CcSEcCtD
Tolvaptan—Diarrhoea—Paclitaxel—lung cancer	0.000115	0.00066	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—lung cancer	0.000114	0.000652	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—lung cancer	0.000114	0.000651	CcSEcCtD
Tolvaptan—Dizziness—Etoposide—lung cancer	0.000114	0.000651	CcSEcCtD
Tolvaptan—ABCB1—bone marrow—lung cancer	0.000114	0.0166	CbGeAlD
Tolvaptan—Immune system disorder—Doxorubicin—lung cancer	0.000113	0.000649	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—lung cancer	0.000113	0.000647	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—lung cancer	0.000113	0.000646	CcSEcCtD
Tolvaptan—Dizziness—Paclitaxel—lung cancer	0.000112	0.000638	CcSEcCtD
Tolvaptan—Nausea—Cisplatin—lung cancer	0.000112	0.000638	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—lung cancer	0.000109	0.000625	CcSEcCtD
Tolvaptan—Headache—Etoposide—lung cancer	0.000108	0.000616	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—lung cancer	0.000107	0.000612	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000107	0.000611	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—lung cancer	0.000106	0.000607	CcSEcCtD
Tolvaptan—Headache—Paclitaxel—lung cancer	0.000106	0.000604	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—lung cancer	0.000105	0.000602	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—lung cancer	0.000103	0.000589	CcSEcCtD
Tolvaptan—ABCB1—lung—lung cancer	0.000103	0.015	CbGeAlD
Tolvaptan—Asthenia—Docetaxel—lung cancer	0.000103	0.000587	CcSEcCtD
Tolvaptan—Nausea—Etoposide—lung cancer	0.000102	0.000584	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—lung cancer	0.000101	0.00058	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—lung cancer	0.000101	0.000578	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—lung cancer	0.000101	0.000578	CcSEcCtD
Tolvaptan—Nausea—Paclitaxel—lung cancer	0.0001	0.000573	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—lung cancer	0.0001	0.000572	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—lung cancer	9.86e-05	0.000564	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—lung cancer	9.83e-05	0.000562	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—lung cancer	9.81e-05	0.000561	CcSEcCtD
Tolvaptan—Diarrhoea—Docetaxel—lung cancer	9.79e-05	0.000559	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—lung cancer	9.61e-05	0.00055	CcSEcCtD
Tolvaptan—Dizziness—Docetaxel—lung cancer	9.46e-05	0.000541	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.25e-05	0.000529	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—lung cancer	9.2e-05	0.000526	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—lung cancer	9.11e-05	0.000521	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—lung cancer	8.96e-05	0.000512	CcSEcCtD
Tolvaptan—Headache—Docetaxel—lung cancer	8.96e-05	0.000512	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—lung cancer	8.93e-05	0.00051	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—lung cancer	8.9e-05	0.000509	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—lung cancer	8.78e-05	0.000502	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—lung cancer	8.75e-05	0.0005	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—lung cancer	8.67e-05	0.000496	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—lung cancer	8.51e-05	0.000486	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—lung cancer	8.5e-05	0.000486	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—lung cancer	8.5e-05	0.000486	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—lung cancer	8.15e-05	0.000466	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—lung cancer	7.76e-05	0.000444	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—lung cancer	7.71e-05	0.000441	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—lung cancer	7.63e-05	0.000436	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—lung cancer	7.6e-05	0.000434	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—lung cancer	7.4e-05	0.000423	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—lung cancer	7.36e-05	0.000421	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—lung cancer	7.29e-05	0.000417	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—lung cancer	7.06e-05	0.000403	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—lung cancer	7.05e-05	0.000403	CcSEcCtD
Tolvaptan—ABCB1—lymph node—lung cancer	7.04e-05	0.0103	CbGeAlD
Tolvaptan—Dizziness—Methotrexate—lung cancer	6.82e-05	0.00039	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—lung cancer	6.58e-05	0.000376	CcSEcCtD
Tolvaptan—Headache—Methotrexate—lung cancer	6.46e-05	0.000369	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—lung cancer	6.41e-05	0.000366	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—lung cancer	6.32e-05	0.000361	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—lung cancer	6.12e-05	0.00035	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—lung cancer	6.11e-05	0.000349	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—lung cancer	5.9e-05	0.000337	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—lung cancer	5.59e-05	0.00032	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—lung cancer	5.3e-05	0.000303	CcSEcCtD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	3.4e-05	0.000337	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—lung cancer	3.39e-05	0.000336	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TERT—lung cancer	3.38e-05	0.000335	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—lung cancer	3.37e-05	0.000334	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TERT—lung cancer	3.36e-05	0.000333	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.35e-05	0.000333	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGFR1—lung cancer	3.28e-05	0.000325	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGFR1—lung cancer	3.26e-05	0.000323	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HIF1A—lung cancer	3.23e-05	0.00032	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	3.23e-05	0.00032	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	3.21e-05	0.000318	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIF1A—lung cancer	3.21e-05	0.000318	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLBD1—lung cancer	3.21e-05	0.000318	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.13e-05	0.00031	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOA1—lung cancer	3.12e-05	0.000309	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOA1—lung cancer	3.1e-05	0.000307	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	3.09e-05	0.000307	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KDR—lung cancer	3.09e-05	0.000307	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.08e-05	0.000306	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KDR—lung cancer	3.07e-05	0.000304	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	3.07e-05	0.000304	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	3.06e-05	0.000303	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	3.06e-05	0.000303	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.96e-05	0.000294	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD17B10—lung cancer	2.93e-05	0.000291	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.92e-05	0.00029	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APC—lung cancer	2.85e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—lung cancer	2.85e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KIT—lung cancer	2.85e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NRAS—lung cancer	2.85e-05	0.000282	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.84e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APC—lung cancer	2.83e-05	0.00028	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KIT—lung cancer	2.83e-05	0.00028	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—lung cancer	2.83e-05	0.00028	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NRAS—lung cancer	2.83e-05	0.00028	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGF—lung cancer	2.81e-05	0.000279	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGF—lung cancer	2.79e-05	0.000277	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.73e-05	0.00027	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK3—lung cancer	2.73e-05	0.00027	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CKB—lung cancer	2.73e-05	0.00027	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.72e-05	0.00027	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—lung cancer	2.71e-05	0.000269	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK3—lung cancer	2.71e-05	0.000268	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—lung cancer	2.69e-05	0.000267	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.69e-05	0.000267	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BRAF—lung cancer	2.68e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BRAF—lung cancer	2.66e-05	0.000263	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6R—lung cancer	2.64e-05	0.000262	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CREBBP—lung cancer	2.64e-05	0.000262	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.63e-05	0.000261	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6R—lung cancer	2.63e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CREBBP—lung cancer	2.62e-05	0.00026	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.61e-05	0.000258	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AZIN2—lung cancer	2.61e-05	0.000258	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—lung cancer	2.59e-05	0.000257	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—lung cancer	2.58e-05	0.000255	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM2—lung cancer	2.56e-05	0.000254	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CNDP2—lung cancer	2.56e-05	0.000254	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAP2K1—lung cancer	2.52e-05	0.00025	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CD—lung cancer	2.5e-05	0.000248	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAP2K1—lung cancer	2.5e-05	0.000248	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTMR3—lung cancer	2.49e-05	0.000247	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CD—lung cancer	2.49e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.48e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—lung cancer	2.46e-05	0.000244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—lung cancer	2.45e-05	0.000243	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.44e-05	0.000242	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—lung cancer	2.43e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PGAM1—lung cancer	2.43e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.38e-05	0.000236	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.37e-05	0.000235	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2A7—lung cancer	2.32e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.3e-05	0.000228	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.29e-05	0.000227	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SDC4—lung cancer	2.27e-05	0.000225	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—lung cancer	2.25e-05	0.000223	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MDM2—lung cancer	2.24e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—lung cancer	2.24e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RAF1—lung cancer	2.24e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MDM2—lung cancer	2.23e-05	0.000221	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RAF1—lung cancer	2.22e-05	0.00022	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ATP5H—lung cancer	2.22e-05	0.00022	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB2—lung cancer	2.21e-05	0.000219	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—lung cancer	2.21e-05	0.000219	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB2—lung cancer	2.2e-05	0.000218	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.19e-05	0.000217	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTOR—lung cancer	2.18e-05	0.000216	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—lung cancer	2.18e-05	0.000216	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—lung cancer	2.17e-05	0.000215	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTOR—lung cancer	2.17e-05	0.000215	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.13e-05	0.000211	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—lung cancer	2.1e-05	0.000208	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—lung cancer	2.08e-05	0.000207	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—lung cancer	2.08e-05	0.000206	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.07e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—lung cancer	2.07e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA3—lung cancer	2.07e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—RRM1—lung cancer	2.07e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—lung cancer	2.03e-05	0.000201	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—lung cancer	2.01e-05	0.000199	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—lung cancer	2.01e-05	0.000199	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—lung cancer	2e-05	0.000199	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—lung cancer	1.99e-05	0.000198	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—lung cancer	1.99e-05	0.000198	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—lung cancer	1.99e-05	0.000197	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—lung cancer	1.98e-05	0.000196	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLBD1—lung cancer	1.97e-05	0.000196	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.97e-05	0.000195	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.96e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—lung cancer	1.95e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUN—lung cancer	1.95e-05	0.000193	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—B4GALT5—lung cancer	1.94e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—lung cancer	1.94e-05	0.000192	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUN—lung cancer	1.94e-05	0.000192	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.91e-05	0.000189	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—lung cancer	1.9e-05	0.000188	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—lung cancer	1.89e-05	0.000187	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA4—lung cancer	1.89e-05	0.000187	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—lung cancer	1.89e-05	0.000187	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—lung cancer	1.88e-05	0.000187	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—lung cancer	1.88e-05	0.000186	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—lung cancer	1.87e-05	0.000186	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.86e-05	0.000185	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA2—lung cancer	1.84e-05	0.000183	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—lung cancer	1.84e-05	0.000182	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—lung cancer	1.83e-05	0.000181	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD17B10—lung cancer	1.81e-05	0.000179	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EP300—lung cancer	1.8e-05	0.000178	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EP300—lung cancer	1.79e-05	0.000177	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA1—lung cancer	1.78e-05	0.000176	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.76e-05	0.000175	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCC3—lung cancer	1.76e-05	0.000174	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SRC—lung cancer	1.75e-05	0.000173	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SRC—lung cancer	1.74e-05	0.000172	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—lung cancer	1.7e-05	0.000169	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKR1C1—lung cancer	1.7e-05	0.000169	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—lung cancer	1.69e-05	0.000168	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—lung cancer	1.69e-05	0.000167	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NRAS—lung cancer	1.68e-05	0.000167	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CKB—lung cancer	1.68e-05	0.000166	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—lung cancer	1.67e-05	0.000166	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NRAS—lung cancer	1.67e-05	0.000166	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UGT1A1—lung cancer	1.65e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.62e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—lung cancer	1.61e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—lung cancer	1.6e-05	0.000159	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GNG11—lung cancer	1.59e-05	0.000158	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CNDP2—lung cancer	1.58e-05	0.000157	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM2—lung cancer	1.58e-05	0.000157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—lung cancer	1.57e-05	0.000155	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.57e-05	0.000155	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—lung cancer	1.56e-05	0.000154	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTMR3—lung cancer	1.54e-05	0.000152	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—lung cancer	1.53e-05	0.000152	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—lung cancer	1.52e-05	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDOA—lung cancer	1.52e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.51e-05	0.000149	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PGAM1—lung cancer	1.5e-05	0.000148	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOA3—lung cancer	1.47e-05	0.000146	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—lung cancer	1.45e-05	0.000144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—lung cancer	1.44e-05	0.000143	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADCY1—lung cancer	1.43e-05	0.000142	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG2—lung cancer	1.43e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2A7—lung cancer	1.43e-05	0.000142	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO2—lung cancer	1.4e-05	0.000139	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HPGDS—lung cancer	1.4e-05	0.000139	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SDC4—lung cancer	1.4e-05	0.000139	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPP2R1B—lung cancer	1.4e-05	0.000138	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—lung cancer	1.36e-05	0.000135	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2A6—lung cancer	1.35e-05	0.000133	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCLC—lung cancer	1.35e-05	0.000133	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—lung cancer	1.33e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.32e-05	0.000131	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—lung cancer	1.32e-05	0.000131	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—lung cancer	1.29e-05	0.000128	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—lung cancer	1.28e-05	0.000127	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO1—lung cancer	1.28e-05	0.000127	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.28e-05	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA3—lung cancer	1.27e-05	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—RRM1—lung cancer	1.27e-05	0.000126	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—lung cancer	1.23e-05	0.000122	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—lung cancer	1.22e-05	0.000121	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—B4GALT5—lung cancer	1.2e-05	0.000119	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.19e-05	0.000118	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—lung cancer	1.18e-05	0.000117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—lung cancer	1.17e-05	0.000116	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA4—lung cancer	1.16e-05	0.000115	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2E1—lung cancer	1.14e-05	0.000113	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA2—lung cancer	1.13e-05	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NQO1—lung cancer	1.13e-05	0.000112	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA1—lung cancer	1.09e-05	0.000108	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—lung cancer	1.09e-05	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCC3—lung cancer	1.08e-05	0.000107	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.08e-05	0.000107	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—lung cancer	1.08e-05	0.000107	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKR1C1—lung cancer	1.05e-05	0.000104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—STK11—lung cancer	1.02e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UGT1A1—lung cancer	1.02e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GNG11—lung cancer	9.81e-06	9.73e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—lung cancer	9.44e-06	9.36e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDOA—lung cancer	9.34e-06	9.26e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—lung cancer	9.19e-06	9.11e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOA3—lung cancer	9.07e-06	8.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADCY1—lung cancer	8.82e-06	8.75e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG2—lung cancer	8.82e-06	8.75e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMS—lung cancer	8.78e-06	8.7e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—lung cancer	8.67e-06	8.6e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HPGDS—lung cancer	8.65e-06	8.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO2—lung cancer	8.65e-06	8.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.6e-06	8.52e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—lung cancer	8.39e-06	8.32e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCLC—lung cancer	8.29e-06	8.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2A6—lung cancer	8.29e-06	8.22e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A1—lung cancer	8.22e-06	8.15e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ERCC2—lung cancer	8.16e-06	8.09e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO1—lung cancer	7.86e-06	7.8e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA1—lung cancer	7.06e-06	6.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2E1—lung cancer	7.05e-06	6.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NQO1—lung cancer	6.97e-06	6.91e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—lung cancer	6.44e-06	6.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—STK11—lung cancer	6.29e-06	6.23e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—lung cancer	6.13e-06	6.08e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CREBBP—lung cancer	5.97e-06	5.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—lung cancer	5.82e-06	5.77e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—lung cancer	5.66e-06	5.61e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—lung cancer	5.66e-06	5.61e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—lung cancer	5.59e-06	5.54e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—lung cancer	5.51e-06	5.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMS—lung cancer	5.41e-06	5.36e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—lung cancer	5.34e-06	5.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A1—lung cancer	5.07e-06	5.02e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ERCC2—lung cancer	5.02e-06	4.98e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—lung cancer	4.94e-06	4.89e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—lung cancer	4.89e-06	4.85e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA1—lung cancer	4.35e-06	4.31e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—lung cancer	4.26e-06	4.23e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EP300—lung cancer	4.07e-06	4.03e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—lung cancer	3.97e-06	3.93e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—lung cancer	3.78e-06	3.75e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CREBBP—lung cancer	3.68e-06	3.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—lung cancer	3.49e-06	3.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—lung cancer	3.44e-06	3.41e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—lung cancer	3.04e-06	3.01e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—lung cancer	3.01e-06	2.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—lung cancer	3.01e-06	2.98e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—lung cancer	2.63e-06	2.61e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EP300—lung cancer	2.51e-06	2.48e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—lung cancer	2.46e-06	2.44e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—lung cancer	1.85e-06	1.84e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—lung cancer	1.51e-06	1.5e-05	CbGpPWpGaD
